ask our doctors

Factor IX

Get the facts on Factor IX treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Factor IX prevention, screening, research, statistics and other Factor IX related topics. We answer all your qestions about Factor IX.

Question: What is the most important factor in explaining the increasing gender gap in college completion? In 1972, the U.S. Department of Education passed Title IX, which intended to redress gender inequality in schools. Men and women reached parity with respect to college graduation in 1982. Since then, women have overtaken men - in 2004 women earned 58% of Bachelor's degrees awarded in the United States. What specific factor(s) have led to this dramatic change? Opinions are fine, but if you can actually provide some evidence to support your answer, that would be even better.

Answer: Access. For example, in 1972, although I qualified for a prestigious science and technology scholarship and degree program, I was not allowed to attend because I was female. It is most difficult to complete college if one is not allowed to attend college. With access, women have opportunity. What any student does with academic opportunity is dependent upon individual character AND current acculturated role expectations that burden and influence both sexes directly and indirectly, and acculturated behaviors including work ethic, motivation, self-drive, delayed adolescence (which hobbles males more than females), emotional stability (beer kegger / video game / Internet addictions are blamed for some of the statistical decline in male academic performance) and response to economic and military events, such as 9/11 and the war in Iraq, which traditionally correlates with declines in male academic performances.


Factor IX News

International Phase I Trial Results of Recombinant Fusion Protein Linking ...

MarketWatch (press release)
2, 2012 /PRNewswire via COMTEX/ -- CSL Behring today announced the results of a Phase I study evaluating recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP) in patients with severe hemophilia B. Results of the study, ...
 

Shire, Sangamo Ink $13M Up-Front Deal for ZFPs against Hemophilia and ...

Genetic Engineering News
The deal gives Shire exclusive worldwide rights to ZFP Therapeutics® targeting the genes for factor VII, VIII, IX, and X, as approaches for hemophilia A and B, along with three additional gene targets. The firms haven't stated which additional targets ...
 

CSL Behring commences rIX-FP trial in hemophilia patients

Pharmaceutical Business Review
CSL Behring has commenced the global Phase II/III, multi-centre study to assess the safety, efficacy and pharmacokinetics of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP). rIX-FP is indicated for the ...
 

Proactive Investors USA & Canada

Biogen 4th quarter profit up; 2012 forecast falls short
Reuters
 

46 reasons to watch today's Super Bowl in Indiananpolis

Rockford Register Star
Let us count the ways: I. The revenge factor, as the Patriots try to get back at the Giants for ruining their perfect 2007 season in Super Bowl XLII. II. A chance to see Giants WR Victor Cruz catch, run and potentially salsa-dance. III.
 

PWHs Demand Free Traetment in Punjab and Candigarh

Punjab Newsline
Sharing his views Dr Vijay Kaul a founder Member of Indian Haemophilia federation urged the UT Administration of Chandigarh and Punjab government to immediately extend the facility to provide free factor VIII and IX to the PWHs as being given in the ...
 

PROLOR Biotech Announces Positive Top-Line Results From Pilot Study of Its ...

MarketWatch (press release)
It also is developing long-acting versions of Factor VIIa and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist peptide for diabetes and obesity, as well as agents for atherosclerosis and rheumatoid arthritis, which are all in ...
 

PROLOR Biotech Announces Positive Top-Line Results From Pilot Study of Its ...

PR Newswire (press release)
It also is developing long-acting versions of Factor VIIa and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist peptide for diabetes and obesity, as well as agents for atherosclerosis and rheumatoid arthritis, which are all in ...
 

9 to 5 Mac

Behringer Unveils New iPad-Based iX Mixer Series
Mobile Magazine
 

Title IX Examined: Investigating Equality in Choate Athletics

The Choate News
Dr. Harris claimed that the NCLA is violating a law called ?Title IX.? The Title IX section of the Education Amendments of 1972 states that ?No person in the United States shall, on the basis of sex, be excluded from participation in, be denied the ...